Targeting the ACSS1/SCD axis offers a promising strategy for metastatic OS.<h4>The translational potential of this article</h4>This study reveals the therapeutic potential of targeting ACSS1/SCD axis, for example, by specific small-molecule inhibitors in treating osteosarcoma metastasis, in addition to conventional chemotherapies. Here, ACSS1 is linked to osteosarcoma.